comparemela.com

Latest Breaking News On - Cardiol therapeutics inc - Page 3 : comparemela.com

AXS Investments LLC Reduces Stock Holdings in Cardiol Therapeutics Inc. (NASDAQ:CRDL)

AXS Investments LLC Reduces Stock Holdings in Cardiol Therapeutics Inc. (NASDAQ:CRDL)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Exchange-commission
Axs-investments
Canaccord-genuity-group
Tejara-capital-ltd
Nasdaq
Cardiol-therapeutics-inc
Cardiol-therapeutics
Free-report
Capital-ltd
Get-free-report
Genuity-group

Baystreet.ca - Adventus, Celestica, Computer Modeling at 52-Week Highs

Baystreet.ca - Adventus, Celestica, Computer Modeling at 52-Week Highs
baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.

Thomson-reuters-corporation
Fortuna-silver-mines-inc
George-weston-limited
Silvercorp-metals-inc
Celestica-inc
Denison-mines-corp
Sustainable-power-infrastructure-split-corp
Loblaw-companies-limited
Orogen-royalties-inc
Newcore-gold-ltd
Cardiol-therapeutics-inc

Thursday's analyst upgrades and downgrades - The Globe and Mail

Thursday's analyst upgrades and downgrades - The Globe and Mail
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.

Oakville
Ontario
Canada
Sunnybrook
Alberta
Toronto
Mexico
Canadian
Cowen-tim-james
Camino-rojo
Benoit-poirier
Canaccord-genuity-edward-nash

Cardiol Therapeutics (NASDAQ:CRDL) Given New $8.00 Price Target at Canaccord Genuity Group

Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) had its price target increased by research analysts at Canaccord Genuity Group from $6.00 to $8.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential […]

Nasdaq
Canaccord-genuity-group
Cardiol-therapeutics-inc
Exchange-commission
Tejara-capital-ltd
Cardiol-therapeutics
Get-free-report
Genuity-group
Therapeutics-trading-down
Capital-ltd
Free-report

Baystreet.ca - Cannabix Technologies, Dividend 15 Split, Dollarama at 52-Week Highs on News

Cannabix Technologies Inc (C.BLO) hit a new 52-week high of 82 cents Thursday. Cannabix Technologies has formed a strategic partnership with Omega Laboratories to bring its marijuana breathalyzer technology to market. Dividend 15 Split Corp. II .

China
Canada
Canadian
Ceres-global-ag-corp
Major-drilling-group-international-inc
Income-fund
Manulife-financial-corporation
Montage-gold-corp
Perseus-mining-limited
Lara-exploration-ltd
Regulus-resources-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.